MedTrace Logo

Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery

NCT02881554 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2025-10-29

Study results available
· View outcomes & findings →

Summary

This pilot trial studies how well single photon emission computed tomography (SPECT)/computed tomography (CT) with technetium Tc-99m sulfur colloid works in measuring liver function in patients with liver cancer that has or has not spread to other place in the body who are undergoing radiation therapy or surgery. Diagnostic procedures, such as sulfur colloid SPECT/CT scans, may measure normal liver tissue before, during and after treatment and help doctors plan better treatment for liver cancer patients.

Conditions

  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • Stage IV Liver Cancer
  • Stage IVA Liver Cancer
  • Stage IVB Liver Cancer
  • Vascular Thrombosis

Interventions

PROCEDURE

Computed Tomography

Undergo SC SPECT/CT

PROCEDURE

Single Photon Emission Computed Tomography

Undergo SC SPECT/CT

DRUG

Technetium Tc-99m Sulfur Colloid

Given IV

Sponsors & Collaborators

Principal Investigators

  • Smith Apisarnthanarax · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-21
Primary Completion
2024-07-31
Completion
2025-02-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02881554 on ClinicalTrials.gov